Trial Illness Likely Not Linked to Covid Shot, Oxford Says (1)

Sept. 16, 2020, 5:27 PM UTC

Symptoms that prompted the University of Oxford and partner AstraZeneca Plc to pause trials evaluating their experimental coronavirus vaccine probably weren’t related to the shot itself, according to documents sent to participants.

Safety reviews were carried out when volunteers in the Oxford study developed unexplained neurological symptoms including limb weakness or “changed sensation,” a participant information sheet posted onlineby Oxford shows.

“After independent review, these illnesses were either considered unlikely to be associated with the vaccine or there was insufficient evidence to say for certain that the illnesses were or were not related to the vaccine,” the letter reads. ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.